%0 Journal Article %1 Buttel2010 %A Buttel, I C %A Voller, K %A Schneider, C K %D 2010 %E Saf, Curr Drug %J Curr Drug Saf %K kalinke %N 4 %P 287-292 %T Immunogenicity and its Impact on Benefit/Risk Considerations in the Authorisation of Biopharmaceuticals. %U http://www.ncbi.nlm.nih.gov/pubmed/20615175 %V 5

@article{Buttel2010, added-at = {2011-03-21T12:21:35.000+0100}, author = {Buttel, I C and Voller, K and Schneider, C K}, biburl = {https://www.bibsonomy.org/bibtex/2b4d7476e4a7862917bc09e40f880e6c8/kalinke}, editor = {Saf, Curr Drug}, groups = {public}, interhash = {53505cca09e0bf7bc4df178e98344d31}, intrahash = {b4d7476e4a7862917bc09e40f880e6c8}, journal = {Curr Drug Saf}, keywords = {kalinke}, number = 4, pages = {287-292}, pubmedurl = {http://www.ncbi.nlm.nih.gov/pubmed/20615175}, timestamp = {2012-05-30T13:08:07.000+0200}, title = {Immunogenicity and its Impact on Benefit/Risk Considerations in the Authorisation of Biopharmaceuticals.}, url = {http://www.ncbi.nlm.nih.gov/pubmed/20615175}, username = {kalinke}, volume = 5, year = 2010 }